Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors

Recruiting Phase 1 Interventional Study
Nicotine Vaping Nicotine Use Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
15 – 25
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
189 (estimated)
Sponsor
Washington University School of Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Use of vaping products (e.g., electronic nicotine delivery systems, e-cigarettes) has been increasing rapidly, particularly among teens and young adults. With limited information on the long-term effects of vaping products, health information about vaping has been somewhat unclear in regards to associated health risks. Teens and young adults may be reluctant to disclose their use of vaping product…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * US Resident * English Speaking * Have daily access to a smartphone * Current vaping product user (P30D) * Identified as socially networking about a desire to quit vaping and/or experiencing negative health outcomes due to vaping * Vaping product user only (i.e., not using vapi…
Contacts

Patricia Cavazos-Rehg, PhD

314-362-2152

pcavazos@wust.edu

CONTACT

Erin Kasson, MSW

314-362-9003

erinmkasson@wustl.edu

CONTACT